Gene · 5406
Papers3,840
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,840
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A machine learning-assisted colorimetric sensor array based on Fe-doped MnO₂/graphene composites for flavonoid identification and bioactivity prediction in vine tea. | Food Chem | 2026 | 42785022 | PubTator, text mining | PubMed |
| Chemical and Enantioselective Characterization and Preliminary Biological Activities of Aristolochia lingulata Aerial-Part Essential Oil. | Plants (Basel) | 2026 | 42739459 | PubTator, text mining | PubMed |
| Lipase ITB 2.1: a structure- and function-validated model for anti-obesity drug screening. | Mol Divers | 2026 | 42732036 | PubTator, text mining | PubMed |
| Bioactive structural features of natural polysaccharides: Inspiration for novel polymer strategies against metabolic disorders. | Carbohydr Res | 2026 | 42715720 | PubTator, text mining | PubMed |
| A Systematic Review and Meta-Analysis of Malnutrition and Metabolic Failure in High-Potency Incretin Therapy. | Obes Sci Pract | 2026 | 42707648 | PubTator, text mining | PubMed |
| Virtual screening of human pancreatic lipase inhibitors using an integrated transfer learning and molecular dynamics simulation. | Bioinformation | 2026 | 42701742 | PubTator, text mining | PubMed |
| [Two new indole alkaloids from Nelumbinis Folium and their hypolipidemic activities]. | Zhongguo Zhong Yao Za Zhi | 2026 | 42693050 | PubTator, text mining | PubMed |
| Antiobesity, antidiabetic, and antioxidant activities of selected Rubia species (Rubiaceae) and LC-MS/MS-based chemical profiling. | Turk J Med Sci | 2026 | 42677271 | PubTator, text mining | PubMed |
| Comparative Characterisation and In Vitro Metabolic Bioactivities of Fucoidan-Rich Extracts from Three South African Brown Macroalgae. | Molecules | 2026 | 42653904 | PubTator, text mining | PubMed |
| Elevated ozone reprograms secondary metabolism in Abelmoschus moschatus pods, enhancing antidiabetic and antiobesity bioactivities. | Plant Cell Rep | 2026 | 42622685 | PubTator, text mining | PubMed |
| In Vitro Inhibition of Digestive Enzymes by Leaf Metabolites from Neurolaena lobata (L.) R. Br. ex Cass. (Asteraceae). | Molecules | 2026 | 42588445 | PubTator, text mining | PubMed |
| A Donkey Blood-Derived Bioactive Peptide (YPWTQ) Alleviates Insulin Resistance in HepG2 Cells Through Multi-Target Regulation of Glucose and Lipid Metabolism and Oxidative Stress. | Nutrients | 2026 | 42588070 | PubTator, text mining | PubMed |
| Influence of Aqueous, Ethanolic, and Hydroethanolic Extraction on Phytochemical Content and Cardiometabolic-Related Bioactivities of Four Cameroonian Spices. | Biomed Res Int | 2026 | 42552769 | PubTator, text mining | PubMed |
| Blackcurrant (Ribes nigrum L.) Matrices: Polyphenol Release, Antioxidant Capacity and Enzyme Inhibitory Potential. | Antioxidants (Basel) | 2026 | 42510514 | PubTator, text mining | PubMed |
| The effect of ultra-fine grinding combined Trichoderma viride fermentation technology on the functional characteristics of wheat bran dietary fiber. | J Food Sci Technol | 2026 | 42502593 | PubTator, text mining | PubMed |
| Phytochemical Profiling and Evaluation of Antioxidant and Enzyme Inhibitory Activities of Selected Endemic Salvia Species (Lamiaceae) From Türkiye. | Food Sci Nutr | 2026 | 42494621 | PubTator, text mining | PubMed |
| In vitro inhibitory effects of Hypoxis hemerocallidea and Pentanisia prunelloides on α-amylase, α-glucosidase and pancreatic lipase activities associated with obesity-related metabolic disorders. | BMC Complement Med Ther | 2026 | 42471702 | PubTator, text mining | PubMed |
| Phytochemical profiling, network pharmacology, and molecular dynamics simulations of Sinularia levi metabolites as potential α-glucosidase inhibitors in metabolic syndrome. | RSC Adv | 2026 | 42444678 | PubTator, text mining | PubMed |
| Chemical constituents of Bauhinia brachycarpa and their inhibitory activities against α-glucosidase and pancreatic lipase. | Fitoterapia | 2026 | 42435990 | PubTator, text mining | PubMed |
| Revised safety evaluation of the food enzyme triacylglycerol lipase from the non-genetically modified Burkholderia stagnalis strain PL266-QLM. | EFSA J | 2026 | 42416397 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5406/papers